Literature DB >> 16493621

Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.

Massimo Franchini1.   

Abstract

Hereditary hemochromatosis, a very common genetic defect in the Caucasian population, is characterized by progressive tissue iron overload which leads to irreversible organ damage if it is not treated timely. The elucidation of the molecular pathways of iron transport through cells and its control has led to the understanding of various genetic iron-loading conditions. Four types of inherited iron overload have been recognized: type 1, the most common form with an autosomal recessive inheritance, is associated with mutations in the HFE gene on chromosome 6; type 2 (juvenile hemochromatosis) is an autosomal recessive disorder with causative mutations identified in the HJV gene (subtype A) on chromosome 1 and the HAMP gene (subtype B) on chromosome 19; type 3 has also an autosomal recessive inheritance with mutations in the TfR2 gene on chromosome 3; type 4 is an autosomal dominant condition with heterozygous mutations in the ferroportin 1 gene on chromosome 2. In this review, the genetics, pathophysiology, diagnosis, clinical features, and management of these different types of hereditary hemochromatosis are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493621     DOI: 10.1002/ajh.20493

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  Effect of hereditary haemochromatosis genotypes and iron overload on other trace elements.

Authors:  Jeffrey M Beckett; Madeleine J Ball
Journal:  Eur J Nutr       Date:  2012-02-09       Impact factor: 5.614

2.  Serum ferritin levels correlate with haemoglobin concentration: a report on 589 outpatients from a single centre.

Authors:  Massimo Franchini; Gian Luca Salvagno; Martina Montagnana; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  Current applications of therapeutic phlebotomy.

Authors:  Tarek Bou Assi; Elizabeth Baz
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

4.  Blood and iron.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2015-05       Impact factor: 4.599

Review 5.  Metabolic crosstalk between host and pathogen: sensing, adapting and competing.

Authors:  Andrew J Olive; Christopher M Sassetti
Journal:  Nat Rev Microbiol       Date:  2016-03-07       Impact factor: 60.633

6.  Polystyrene microsphere-ferritin conjugates: a robust phantom for correlation of relaxivity and size distribution.

Authors:  Preeti A Sukerkar; Uzma G Rezvi; Keith W Macrenaris; Pinal C Patel; John C Wood; Thomas J Meade
Journal:  Magn Reson Med       Date:  2010-10-28       Impact factor: 4.668

7.  Two middle-age-onset hemochromatosis patients with heterozygous mutations in the hemojuvelin gene in a Chinese family.

Authors:  Shufeng Li; Jun Xue; Baojun Chen; Qiwei Wang; Minke Shi; Xiaojing Xie; Liang Zhang
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

8.  Synthesis of 5-dialkyl(aryl)aminomethyl-8-hydroxyquinoline dansylates as selective fluorescent sensors for Fe3+.

Authors:  Ruogu Peng; Feng Wang; Yaowu Sha
Journal:  Molecules       Date:  2007-05-31       Impact factor: 4.411

9.  Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.

Authors:  Victor R Gordeuk; David M Reboussin; Christine E McLaren; James C Barton; Ronald T Acton; Gordon D McLaren; Emily L Harris; Jacob A Reiss; Paul C Adams; Mark Speechley; Pradyumna D Phatak; Phyliss Sholinsky; John H Eckfeldt; Wen-Pin Chen; Leah Passmore; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-08       Impact factor: 10.047

10.  Unusual presentation of hemochromatosis as isolated metacarpophalangeal joint osteoarthritis: a case report.

Authors:  Sunishka M Wimalawansa; Rannie Alsamkari
Journal:  Hand (N Y)       Date:  2011-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.